Michael Hemann

Professor Michael Hemann’s lab addresses the issue that many human cancers do not respond to chemotherapy, and oftentimes those that initially respond eventually acquire drug resistance. They use high-throughput screening technology — combined with mouse stem cell reconstitution and tumor transplantation systems — to investigate the genetic basis for this resistance. The goal is to identify novel cancer drug targets, as well as strategies for tailoring existing cancer therapies to target the vulnerabilities associated with specific malignancies.

Sort options

Genetics: The Fundamentals (edX)

Self Paced
Genetics: The Fundamentals (edX)
Course Auditing
Categories
Effort
Languages
How do we know what we know about heredity? Enhance your scientific thinking and experimental design skills with this in-depth adventure through genetics. How do we study the inheritance of different traits? How does that information help us understand heritable diseases? Professors Michael Hemann and Peter Reddien will challenge [...]